Kjell Bäckström

Title: Kjell Bäckström: Innovator in Aerosol Drug Formulations

Introduction

Kjell Bäckström is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of aerosol drug formulations, particularly in the development of innovative inhalation therapies. His work has the potential to improve the delivery of medications for respiratory conditions.

Latest Patents

Kjell Bäckström holds a patent for "Aerosol drug formulations containing hydrofluoroalkanes and alkyl saccharides." This patent describes aerosol formulations suitable for use in pressurized metered dose inhalers. The formulations comprise a hydrofluoroalkane propellant, a medicament for inhalation, and a surfactant, which can be a C–C fatty acid or salt thereof, a bile salt, a phospholipid, or an alkyl saccharide. He has 1 patent to his name.

Career Highlights

Kjell Bäckström is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has focused on advancing aerosol drug delivery systems, which are crucial for patients with respiratory diseases. His innovative approach has contributed to the development of more effective inhalation therapies.

Collaborations

Kjell has collaborated with notable colleagues, including Magnus Dahlbäck and Ann Charlotte Johansson. These collaborations have fostered a productive environment for innovation and research within the field of aerosol formulations.

Conclusion

Kjell Bäckström's contributions to aerosol drug formulations highlight his role as an important inventor in the pharmaceutical industry. His work continues to influence the development of effective inhalation therapies for patients worldwide.